Evidence map›Paper›PMID 29209985›Full record

ArticlePathology oncology research : POR2019

Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.

Bjoern Schneider, Katrin Riedel, Andrey Zhivov, Maja Huehns, Heike Zettl, Rudolf F Guthoff, Anselm Jünemann, Andreas Erbersdobler, Annette Zimpfer

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Photoperiod Induces the Epigenetic Change of theInternational journal of molecular sciences · 2023
    Article
  6. Review
  7. Cancers · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. [New treatment options for iridociliary tumors].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019
    Review
  15. Article
  16. Article
  17. LncRNAs in ocular neovascularizations.International journal of ophthalmology · 2019
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bjoern SchneiderInstitute of Pathology, University Medicine Rostock, Strempelstraße 14, 18055, Rostock, Germany. bjoern.schneider@med.uni-rostock.de.ORCID http://orcid.org/0000-0002-0282-7330
Katrin RiedelDepartment of Ophthalmology, University Medicine Rostock, Rostock, Germany.
Andrey ZhivovOSG MVZ Betriebs GmbH, Ophtalmology, OMS, Anesthetics, Bamberg, Germany.
Maja HuehnsInstitute of Pathology, University Medicine Rostock, Strempelstraße 14, 18055, Rostock, Germany.
Heike ZettlClinical Cancer Registry, University Medicine Rostock, Rostock, Germany.
Rudolf F GuthoffDepartment of Ophthalmology, University Medicine Rostock, Rostock, Germany.
Anselm JünemannDepartment of Ophthalmology, University Medicine Rostock, Rostock, Germany.
Andreas ErbersdoblerInstitute of Pathology, University Medicine Rostock, Strempelstraße 14, 18055, Rostock, Germany.
Annette ZimpferInstitute of Pathology, University Medicine Rostock, Strempelstraße 14, 18055, Rostock, Germany.
University of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma of the uvea is the most common primary malignant tumor in the eye. We aimed to analyze GNAQ and GNA11 mutations in uveal melanomas using formalin-fixed, paraffin-embedded material and correlate the results with clinicopathological parameters. Tumor tissue was microdissected followed by amplification of GNAQ exon 4 and 5, GNA11 exon 4 and 5, and finally analyzed by Sanger sequencing. A total of 64.4 GNA11/GNAQ mutations, including ten yet unreported, were found. Two cases showed multiple mutations. Overall survival was significantly shorter in the uveal melanoma cohort with GNAQ exon 5 mutation. In concordance with previous studies, high frequencies of mutations in GNAQ or GNA11 were detected. Interestingly, in about 20% of UM, not yet reported mutations in GNAQ or GNA11 were seen. Rarely, uveal melanoma may harbor double mutations in GNAQ and/or GNA11. Recent data imply, that implementation of GNAQ/GNA11 mutation analysis in routine diagnostic procedures might be helpful for future therapeutic decisions.

Indexed as

MutationAdultAgedAged, 80 and overBiomarkers, TumorDNA Mutational AnalysisFemaleFollow-Up StudiesGene Expression Regulation, NeoplasticGTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gq-G11HumansMaleMelanomaMiddle AgedPrognosisBiomarkers, TumorGNA11 protein, humanGNAQ protein, humanGTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gq-G11Driver mutation frequencyGNAQ/GNA11 mutationSurvivalUveal melanoma

Identifiers

PMID29209985
OpenAlexW2774011909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.